###begin article-title 0
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 59 64 <span type="species:ncbi:9606">Human</span>
Expression of GAD67 and Novel GAD67 Splice Variants During Human Fetal Pancreas Development
###end article-title 0
###begin p 1
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD</italic>
###xml 119 120 119 120 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 185 188 181 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD</italic>
###xml 407 412 403 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 417 422 413 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 608 613 604 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 623 628 619 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 901 906 897 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 457 462 <span type="species:ncbi:9606">human</span>
###xml 666 671 <span type="species:ncbi:9606">human</span>
###xml 843 848 <span type="species:ncbi:9606">human</span>
###xml 943 948 <span type="species:ncbi:9606">human</span>
Glutamic acid decarboxylase (GAD) is a major inhibitory neurotransmitter in the brain, which catalyses the reaction of l-glutamate to gamma-aminobutyric acid. There are two isoforms of GAD, a 65-kDa form and a 67-kDa form, which are encoded by two different genes. As previous studies suggested a role for GAD67 splice variants during fetal pancreas development, we have investigated the mRNA expression of GAD67 and GAD67 splice variants in a series of 14 human fetal pancreases between 14 weeks gestation and term and in adult control pancreases by RT-PCR. In this study, we demonstrate mRNA expression of GAD67 and four GAD67 splice variants, including GAD25, in human fetal and adult specimens. Some of the splice variants, including various proportions of exon 7 or a new exon between exons 6 and 7, have not been described before in the human pancreas. We speculate that the expression of these GAD67 splice variants might be related to human fetal pancreas development.
###end p 1
###begin title 2
Keywords
###end title 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD</italic>
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD65</italic>
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 124 129 124 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD65</italic>
###xml 134 139 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 182 183 182 183 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 197 202 197 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#947;</italic>
###xml 297 300 293 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD</italic>
###xml 367 368 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 371 376 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD65</italic>
###xml 412 417 408 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 435 436 431 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 467 472 463 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 532 533 528 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 535 536 531 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
Two forms of glutamic acid decarboxylase (GAD) occur in mammalian tissues: a 65 kDa form (GAD65) and a 67-kDa form (GAD67). GAD65 and GAD67 are enzymes that catalyze the reaction of l-glutamate to gamma-aminobutyric acid, a major inhibitory neurotransmitter in the central nervous system. The two GAD isoforms are highly homologous but are encoded by separate genes [1]. GAD65 is localized on chromosome 10, and GAD67 on chromosome 2 [2]. Alternative splicing of the GAD67 gene can result in two additional isoforms of the protein [3, 4].
###end p 4
###begin p 5
###xml 424 425 421 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 534 535 531 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 536 537 533 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 3 9 <span type="species:ncbi:9606">humans</span>
###xml 120 128 <span type="species:ncbi:9606">patients</span>
###xml 283 291 <span type="species:ncbi:9606">patients</span>
###xml 491 499 <span type="species:ncbi:9606">patients</span>
In humans, autoreactivity against GAD is often found in type 1 diabetes mellitus. Some 10 to 30% of the newly diagnosed patients have GAD67 antibodies, and up to 80% have GAD65 antibodies. Because the prevalence of GAD67 autoreactivity is less than GAD65, and is usually detected in patients with GAD65 antibodies, the GAD67 antibodies are assumed to play a less prominent role in the pathogenesis of beta-cell destruction [3]. However, there are studies where GAD67 reactivity was found in patients without reactivity against GAD65 [5-7].
###end p 5
###begin p 6
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD65</italic>
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD65</italic>
###xml 174 179 174 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 294 295 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 297 298 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 498 503 498 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 505 506 505 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 508 509 508 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 519 521 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 137 142 <span type="species:ncbi:9606">human</span>
###xml 363 368 <span type="species:ncbi:9606">human</span>
###xml 424 427 <span type="species:ncbi:10116">rat</span>
###xml 463 468 <span type="species:ncbi:10090">mouse</span>
GAD65 and GAD67 are both highly expressed in the brain, but the two forms appear to be differentially expressed in pancreatic islets. In human islets, GAD65 is abundant, but GAD67 could not be detected with immunohistochemistry, in situ hybridization, immunoprecipitation, or Western blotting [3, 8-10]. In one study, limited GAD67 expression was demonstrated in human islets by RNase protection analysis [11]. In contrast, rat islets express both forms, whereas mouse islets express predominantly GAD67 [4, 8, 10, 12, 13].
###end p 6
###begin p 7
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 233 236 233 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD</italic>
###xml 342 347 342 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 371 372 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 514 519 514 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD25</italic>
###xml 565 570 565 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD44</italic>
###xml 656 661 656 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD44</italic>
###xml 668 670 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1A</xref>
###xml 772 773 772 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 775 777 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 912 917 912 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 1029 1034 1029 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 1073 1078 1073 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 1094 1099 1094 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD25</italic>
###xml 1101 1102 1101 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 1105 1111 1105 1111 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 1</label>
###xml 1162 1167 1162 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 1237 1242 1237 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 1256 1261 1256 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD25</italic>
###xml 1266 1271 1266 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD25</italic>
###xml 1276 1281 1276 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 1290 1295 1290 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 1741 1742 1741 1742 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 1745 1746 1745 1746 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 1836 1841 1836 1841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 1856 1861 1856 1861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD25</italic>
###xml 1884 1889 1884 1889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD44</italic>
###xml 1998 2003 1998 2003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD44</italic>
###xml 1111 2003 1111 2003 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="8">A Schematic representation of exon 6 to exon 10 of <italic>GAD67</italic>, including the localization of the primers used for the RT reaction (<italic>GAD67</italic>.Ar) and PCR (<italic>GAD25</italic>.1f, <italic>GAD25</italic>.1r, <italic>GAD67</italic>.1f, and <italic>GAD67</italic>.1r). In the adult form, exon 7 is spliced out of the mRNA, but in embryonic mouse brain, a part of exon 7 is spliced out in two different ways. Either the first 80 bp (I-80) or the first 86 bp (I-86) is retained in the mRNA, and because an overlapping translation stop-start sequence occurs after 34 nucleotides in exon 7, the I-80 and I-86 inserts result in two &#8220;open reading frames&#8221; (ORFs) and one ORF, respectively, as displayed in subpanel (<bold>B</bold>). <bold>B</bold> Overview of alternative mRNA splice variants, including the predicted ORFs; ORF1 encodes <italic>GAD67</italic>, ORF2 encodes <italic>GAD25</italic>, whereas ORF3 encodes <italic>GAD44</italic>. The additional 6 bp in the I-86 message contains an in-frame stop codon which abolishes the translation of <italic>GAD44</italic></p>
###xml 1111 2003 1111 2003 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="8">A Schematic representation of exon 6 to exon 10 of <italic>GAD67</italic>, including the localization of the primers used for the RT reaction (<italic>GAD67</italic>.Ar) and PCR (<italic>GAD25</italic>.1f, <italic>GAD25</italic>.1r, <italic>GAD67</italic>.1f, and <italic>GAD67</italic>.1r). In the adult form, exon 7 is spliced out of the mRNA, but in embryonic mouse brain, a part of exon 7 is spliced out in two different ways. Either the first 80 bp (I-80) or the first 86 bp (I-86) is retained in the mRNA, and because an overlapping translation stop-start sequence occurs after 34 nucleotides in exon 7, the I-80 and I-86 inserts result in two &#8220;open reading frames&#8221; (ORFs) and one ORF, respectively, as displayed in subpanel (<bold>B</bold>). <bold>B</bold> Overview of alternative mRNA splice variants, including the predicted ORFs; ORF1 encodes <italic>GAD67</italic>, ORF2 encodes <italic>GAD25</italic>, whereas ORF3 encodes <italic>GAD44</italic>. The additional 6 bp in the I-86 message contains an in-frame stop codon which abolishes the translation of <italic>GAD44</italic></p></caption>
###xml 2003 2003 2003 2003 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="12022_2007_Article_3_Fig1" id="MO1"/>
###xml 1105 2003 1105 2003 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig. 1</label><caption><p textid="8">A Schematic representation of exon 6 to exon 10 of <italic>GAD67</italic>, including the localization of the primers used for the RT reaction (<italic>GAD67</italic>.Ar) and PCR (<italic>GAD25</italic>.1f, <italic>GAD25</italic>.1r, <italic>GAD67</italic>.1f, and <italic>GAD67</italic>.1r). In the adult form, exon 7 is spliced out of the mRNA, but in embryonic mouse brain, a part of exon 7 is spliced out in two different ways. Either the first 80 bp (I-80) or the first 86 bp (I-86) is retained in the mRNA, and because an overlapping translation stop-start sequence occurs after 34 nucleotides in exon 7, the I-80 and I-86 inserts result in two &#8220;open reading frames&#8221; (ORFs) and one ORF, respectively, as displayed in subpanel (<bold>B</bold>). <bold>B</bold> Overview of alternative mRNA splice variants, including the predicted ORFs; ORF1 encodes <italic>GAD67</italic>, ORF2 encodes <italic>GAD25</italic>, whereas ORF3 encodes <italic>GAD44</italic>. The additional 6 bp in the I-86 message contains an in-frame stop codon which abolishes the translation of <italic>GAD44</italic></p></caption><graphic position="anchor" xlink:href="12022_2007_Article_3_Fig1" id="MO1"/></fig>
###xml 740 744 <span type="species:ncbi:10090">mice</span>
###xml 968 973 <span type="species:ncbi:9606">human</span>
###xml 1372 1377 <span type="species:ncbi:10090">mouse</span>
In addition to the native form of GAD67, of which exon 7 is spliced out of the mRNA, other forms of alternative splicing of the GAD67 gene have been described in the rodent brain. This alternative splicing resulted in two additional GAD transcripts in which either the first 80 or the first 86 bp of exon 7 were inserted into the full length GAD67 message, respectively [4, 14]. Transcripts with the 80-bp insertion result in two overlapping open reading frames, encoding an enzymatically inactive 25-kDa protein (GAD25) and an enzymatically active 44-kDa protein (GAD44). A second stop codon at the end of the 86-bp insertion abolishes the translation of GAD44 (Fig. 1A). This alternative splicing was only observed in embryonic and fetal mice, but not in adult animals [4, 14, 15], leading to the conclusion that this alternative splice variant could have a developmental function. Alternative splicing of the GAD67 gene has also been demonstrated in cells of adult human pancreatic islets. Exon 7 was inserted after exon 6 of GAD67, resulting in a shorter transcript of GAD67 mRNA, encoding GAD25 [3]. Fig. 1A Schematic representation of exon 6 to exon 10 of GAD67, including the localization of the primers used for the RT reaction (GAD67.Ar) and PCR (GAD25.1f, GAD25.1r, GAD67.1f, and GAD67.1r). In the adult form, exon 7 is spliced out of the mRNA, but in embryonic mouse brain, a part of exon 7 is spliced out in two different ways. Either the first 80 bp (I-80) or the first 86 bp (I-86) is retained in the mRNA, and because an overlapping translation stop-start sequence occurs after 34 nucleotides in exon 7, the I-80 and I-86 inserts result in two "open reading frames" (ORFs) and one ORF, respectively, as displayed in subpanel (B). B Overview of alternative mRNA splice variants, including the predicted ORFs; ORF1 encodes GAD67, ORF2 encodes GAD25, whereas ORF3 encodes GAD44. The additional 6 bp in the I-86 message contains an in-frame stop codon which abolishes the translation of GAD44
###end p 7
###begin p 8
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 145 150 145 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD25</italic>
###xml 155 160 155 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD25</italic>
###xml 165 170 165 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 179 184 179 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 630 631 630 631 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 634 635 634 635 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 725 730 725 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 745 750 745 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD25</italic>
###xml 773 778 773 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD44</italic>
###xml 887 892 887 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD44</italic>
###xml 261 266 <span type="species:ncbi:10090">mouse</span>
A Schematic representation of exon 6 to exon 10 of GAD67, including the localization of the primers used for the RT reaction (GAD67.Ar) and PCR (GAD25.1f, GAD25.1r, GAD67.1f, and GAD67.1r). In the adult form, exon 7 is spliced out of the mRNA, but in embryonic mouse brain, a part of exon 7 is spliced out in two different ways. Either the first 80 bp (I-80) or the first 86 bp (I-86) is retained in the mRNA, and because an overlapping translation stop-start sequence occurs after 34 nucleotides in exon 7, the I-80 and I-86 inserts result in two "open reading frames" (ORFs) and one ORF, respectively, as displayed in subpanel (B). B Overview of alternative mRNA splice variants, including the predicted ORFs; ORF1 encodes GAD67, ORF2 encodes GAD25, whereas ORF3 encodes GAD44. The additional 6 bp in the I-86 message contains an in-frame stop codon which abolishes the translation of GAD44
###end p 8
###begin p 9
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD</italic>
###xml 51 52 51 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 54 56 54 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 122 125 122 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD</italic>
###xml 198 201 198 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD</italic>
###xml 341 346 341 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 351 356 351 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 246 251 <span type="species:ncbi:9606">human</span>
The potential role of GAD in pancreas development [4, 16] and the lack of knowledge of the normal expression of different GAD isoforms during normal fetal pancreas development led us to investigate GAD expression at the mRNA level in a series of human fetal pancreas specimens of 14 weeks gestation until term. In this paper, we demonstrate GAD67 and GAD67 splice variants, including GAD25 mRNA expression by RT-PCR, between 14 weeks gestation and term and in the adult pancreas.
###end p 9
###begin title 10
Materials and Methods
###end title 10
###begin title 11
Tissue Specimens
###end title 11
###begin p 12
###xml 13 14 13 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 30 31 30 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human fetal (n=14) and adult (n=4) pancreatic specimens were retrieved from the Erasmus MC Tissue Bank, Department of Pathology, Rotterdam, The Netherlands, following approval of the experimental design and protocols by the Medical Ethical Committee. The fetuses had died of causes not related to the pancreas. Autopsy was performed within 24 h after death. The adult pancreatic tissue was obtained from normal tissue in pancreatic resection specimens. Histological analyses confirmed the presence of normal tissue in these adult pancreas samples.
###end p 12
###begin p 13
###xml 131 132 131 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 153 154 153 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
Fourteen snap-frozen pancreatic samples between 14 weeks gestation and term (gestational ages: 14, 16, 18, 19, 21, 26, 27, 29, 32 (n=2), 33, 36, and 40 (n=2) weeks, respectively) and four adult snap-frozen pancreatic samples were stored in liquid nitrogen and were used to isolate RNA. Paraffin samples were fixed by immersion in 4% buffered formaldehyde and embedded in paraffin according to the standard procedures.
###end p 13
###begin title 14
RNA Isolation
###end title 14
###begin p 15
###xml 215 216 211 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 284 285 280 281 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Total RNA was extracted using Trizol reagent (Life Technologies, Rockville, MD, USA) following the manufacturer's instructions. After RNA isolation, the quality of 5 microg RNA was checked with an MOPS gel (0.2 M 3-N-morpholinepropanesufonic acid, 0.05 M sodium acetate, and 0.01 M Na2EDTA).
###end p 15
###begin title 16
cDNA Synthesis and PCR Amplification
###end title 16
###begin p 17
###xml 113 118 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 149 155 149 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">POLR2A</italic>
###xml 322 323 318 319 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 688 689 670 671 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 778 780 752 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 879 884 853 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 889 895 863 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">POLR2A</italic>
###xml 903 904 877 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 915 918 889 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq</italic>
###xml 1413 1420 1363 1370 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table 1</label>
###xml 1420 1440 1370 1390 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="18">Primers used for PCR</p>
###xml 1420 1440 1370 1390 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="18">Primers used for PCR</p></caption>
###xml 1440 1451 1390 1401 <th xmlns:xlink="http://www.w3.org/1999/xlink">Specificity</th>
###xml 1451 1466 1401 1416 <th xmlns:xlink="http://www.w3.org/1999/xlink">Forward (5&#8242;&#8211;3&#8242;)</th>
###xml 1466 1481 1416 1431 <th xmlns:xlink="http://www.w3.org/1999/xlink">Reverse (5&#8242;&#8211;3&#8242;)</th>
###xml 1481 1502 1431 1452 <th xmlns:xlink="http://www.w3.org/1999/xlink">Expected product size</th>
###xml 1440 1502 1390 1452 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>Specificity</th><th>Forward (5&#8242;&#8211;3&#8242;)</th><th>Reverse (5&#8242;&#8211;3&#8242;)</th><th>Expected product size</th></tr>
###xml 1440 1502 1390 1452 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th>Specificity</th><th>Forward (5&#8242;&#8211;3&#8242;)</th><th>Reverse (5&#8242;&#8211;3&#8242;)</th><th>Expected product size</th></tr></thead>
###xml 1502 1507 1452 1457 <td xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</td>
###xml 1507 1527 1457 1477 <td xmlns:xlink="http://www.w3.org/1999/xlink">gagaatggctgacatcaacg</td>
###xml 1527 1547 1477 1497 <td xmlns:xlink="http://www.w3.org/1999/xlink">gaagtacttgtagcgagcag</td>
###xml 1547 1553 1497 1503 <td xmlns:xlink="http://www.w3.org/1999/xlink">200 bp</td>
###xml 1502 1553 1452 1503 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>GAD67</td><td>gagaatggctgacatcaacg</td><td>gaagtacttgtagcgagcag</td><td>200 bp</td></tr>
###xml 1553 1558 1503 1508 <td xmlns:xlink="http://www.w3.org/1999/xlink">GAD25</td>
###xml 1558 1575 1508 1525 <td xmlns:xlink="http://www.w3.org/1999/xlink">tttcaaccagctctcca</td>
###xml 1575 1595 1525 1545 <td xmlns:xlink="http://www.w3.org/1999/xlink">tgcagttaccatcacctctg</td>
###xml 1595 1601 1545 1551 <td xmlns:xlink="http://www.w3.org/1999/xlink">189 bp</td>
###xml 1553 1601 1503 1551 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>GAD25</td><td>tttcaaccagctctcca</td><td>tgcagttaccatcacctctg</td><td>189 bp</td></tr>
###xml 1601 1607 1551 1557 <td xmlns:xlink="http://www.w3.org/1999/xlink">POLR2A</td>
###xml 1607 1627 1557 1577 <td xmlns:xlink="http://www.w3.org/1999/xlink">cggatgaactgaagcgaatg</td>
###xml 1627 1647 1577 1597 <td xmlns:xlink="http://www.w3.org/1999/xlink">ttgttagagtccacaagcag</td>
###xml 1647 1653 1597 1603 <td xmlns:xlink="http://www.w3.org/1999/xlink">188 bp</td>
###xml 1601 1653 1551 1603 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>POLR2A</td><td>cggatgaactgaagcgaatg</td><td>ttgttagagtccacaagcag</td><td>188 bp</td></tr>
###xml 1502 1653 1452 1603 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>GAD67</td><td>gagaatggctgacatcaacg</td><td>gaagtacttgtagcgagcag</td><td>200 bp</td></tr><tr><td>GAD25</td><td>tttcaaccagctctcca</td><td>tgcagttaccatcacctctg</td><td>189 bp</td></tr><tr><td>POLR2A</td><td>cggatgaactgaagcgaatg</td><td>ttgttagagtccacaagcag</td><td>188 bp</td></tr></tbody>
###xml 1440 1653 1390 1603 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th>Specificity</th><th>Forward (5&#8242;&#8211;3&#8242;)</th><th>Reverse (5&#8242;&#8211;3&#8242;)</th><th>Expected product size</th></tr></thead><tbody><tr><td>GAD67</td><td>gagaatggctgacatcaacg</td><td>gaagtacttgtagcgagcag</td><td>200 bp</td></tr><tr><td>GAD25</td><td>tttcaaccagctctcca</td><td>tgcagttaccatcacctctg</td><td>189 bp</td></tr><tr><td>POLR2A</td><td>cggatgaactgaagcgaatg</td><td>ttgttagagtccacaagcag</td><td>188 bp</td></tr></tbody></table>
###xml 1413 1653 1363 1603 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table 1</label><caption><p textid="18">Primers used for PCR</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Specificity</th><th>Forward (5&#8242;&#8211;3&#8242;)</th><th>Reverse (5&#8242;&#8211;3&#8242;)</th><th>Expected product size</th></tr></thead><tbody><tr><td>GAD67</td><td>gagaatggctgacatcaacg</td><td>gaagtacttgtagcgagcag</td><td>200 bp</td></tr><tr><td>GAD25</td><td>tttcaaccagctctcca</td><td>tgcagttaccatcacctctg</td><td>189 bp</td></tr><tr><td>POLR2A</td><td>cggatgaactgaagcgaatg</td><td>ttgttagagtccacaagcag</td><td>188 bp</td></tr></tbody></table></table-wrap>
###xml 380 409 <span type="species:ncbi:11801">Moloney murine leukemia virus</span>
One microgram of total RNA from 18 pancreases was reverse-transcribed with a mix of specific reverse primers for GAD67 (5'-AGTGACTCTGTTCTGAGGTG-3'), POLR2A (5'-TTGTTAGAGTCCACAAGCAG-3'), and oligo-dT (T12). cDNA synthesis was performed in a final volume of 20 microl containing 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCl2, 10 mM DTT, 3 pM specific primer mix, 1 mM dNTPs, 200 U Moloney murine leukemia virus (M-MLV) reverse transcriptase (Invitrogen, San Diego, CA, USA), and 30 U RNase inhibitor (Promega, Madison, WI, USA). The RT mix was incubated for 1 h at 37degreesC. Polymerase chain reaction was performed with 1 microl cDNA in a final volume of 15 microl containing 1.5 mM MgCl2; 10 mM Tris-HCl; 50 mM KCl; 0.02 mM dATP; 0.2 mM dGTP, dTTP, and dCTP; 0.8 microCi alpha32P-dATP (Amersham, Buckinghamshire, United Kingdom), 15 pmol of each forward and reverse primer for GAD67 and POLR2A (Table 1), and 1 U Taq polymerase (Promega, Madison, WI, USA). PCR was performed for 35 cycles at 95degreesC for 30 s, 58degreesC for 45 s, and 1 min at 72degreesC, followed by 1 cycle at 72degreesC for 10 min. PCR products were run on a denaturing 6% polyacrylamide gel (Fluka, Neu-Ulm, Germany). After electrophoresis, the gel was dried and exposed to an x-ray film. Negative controls for the RT reaction were performed by omission of either M-MLV reverse transcriptase or RNA, and for the PCR by omission of cDNA. Table 1Primers used for PCRSpecificityForward (5'-3')Reverse (5'-3')Expected product sizeGAD67gagaatggctgacatcaacggaagtacttgtagcgagcag200 bpGAD25tttcaaccagctctccatgcagttaccatcacctctg189 bpPOLR2Acggatgaactgaagcgaatgttgttagagtccacaagcag188 bp
###end p 17
###begin p 18
Primers used for PCR
###end p 18
###begin title 19
DNA Sequencing
###end title 19
###begin p 20
###xml 342 344 330 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
To confirm that the additional bands represented both splicing forms, two 50 microl PCRs were performed with two cDNA samples, respectively, at 14 and 19 weeks. Polymerase chain reaction was performed under the identical conditions as the previous PCR except that this mix contained 0.2 mM dNTPs instead of 0.02 mM dATPs and 0.8 microCi alpha32P-dATP. The PCR products were run on a 2% agarose gel, and the additional bands were excised out of the gel and purified using a QIAquick Gel Extraction Kit (Westburg, Leusden, The Netherlands) according to the manufacturer's instructions. The purified PCR products were commercially sequenced (Baseclear, Leiden, The Netherlands).
###end p 20
###begin title 21
Results
###end title 21
###begin title 22
RT-PCR
###end title 22
###begin p 23
###xml 22 28 22 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">POLR2A</italic>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2A</xref>
###xml 145 150 145 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2C</xref>
###xml 735 740 735 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD25</italic>
###xml 790 795 790 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD25</italic>
###xml 884 885 884 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 986 988 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2C</xref>
###xml 1171 1177 1171 1177 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 2</label>
###xml 1177 1180 1177 1180 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-C</bold>
###xml 1265 1271 1265 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">POLR2A</italic>
###xml 1273 1274 1273 1274 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 1277 1282 1277 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 1284 1285 1284 1285 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 1292 1297 1292 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD25</italic>
###xml 1299 1300 1299 1300 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 1307 1313 1307 1313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 1375 1381 1375 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">POLR2A</italic>
###xml 1383 1384 1383 1384 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 1412 1417 1412 1417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 1433 1434 1433 1434 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 1452 1457 1452 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD25</italic>
###xml 1459 1460 1459 1460 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 1177 1461 1177 1461 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="24"><bold>A-C</bold> Results of RT-PCR experiments of seven representative samples, with primers against <italic>POLR2A</italic> (<bold>A</bold>), <italic>GAD67</italic> (<bold>B</bold>), and <italic>GAD25</italic> (<bold>C</bold>). The <italic>arrows</italic> indicate the sizes of the PCR products, which are 188 bp for <italic>POLR2A</italic> (<bold>A</bold>); 200, 280, and 286 bp for <italic>GAD67</italic>, respectively (<bold>B</bold>); and 189 bp for <italic>GAD25</italic> (<bold>C</bold>)</p>
###xml 1177 1461 1177 1461 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="24"><bold>A-C</bold> Results of RT-PCR experiments of seven representative samples, with primers against <italic>POLR2A</italic> (<bold>A</bold>), <italic>GAD67</italic> (<bold>B</bold>), and <italic>GAD25</italic> (<bold>C</bold>). The <italic>arrows</italic> indicate the sizes of the PCR products, which are 188 bp for <italic>POLR2A</italic> (<bold>A</bold>); 200, 280, and 286 bp for <italic>GAD67</italic>, respectively (<bold>B</bold>); and 189 bp for <italic>GAD25</italic> (<bold>C</bold>)</p></caption>
###xml 1461 1461 1461 1461 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="12022_2007_Article_3_Fig2" id="MO2"/>
###xml 1171 1461 1171 1461 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig. 2</label><caption><p textid="24"><bold>A-C</bold> Results of RT-PCR experiments of seven representative samples, with primers against <italic>POLR2A</italic> (<bold>A</bold>), <italic>GAD67</italic> (<bold>B</bold>), and <italic>GAD25</italic> (<bold>C</bold>). The <italic>arrows</italic> indicate the sizes of the PCR products, which are 188 bp for <italic>POLR2A</italic> (<bold>A</bold>); 200, 280, and 286 bp for <italic>GAD67</italic>, respectively (<bold>B</bold>); and 189 bp for <italic>GAD25</italic> (<bold>C</bold>)</p></caption><graphic position="anchor" xlink:href="12022_2007_Article_3_Fig2" id="MO2"/></fig>
The housekeeping gene POLR2A was used as a positive control for the RT reaction and showed positive results for all samples (Fig. 2A). Using the GAD67 primers, four distinct PCR products per sample were observed. In all samples, a 200-bp amplified product was present, which represents the adult GAD67 isoform, without insertion of exon 7. The 280-bp product and the 286-bp product were highly reproducible and detected in most fetal and all adult samples (Fig. 2C). Three fetal pancreatic samples showed only the 286-bp additional band. An additional PCR product of about 330-bp appeared reproducibly in the majority of samples. This product was sequenced, as well as the 280-bp and the 286-bp PCR products (see below). To detect the GAD25 mRNA, we performed PCR with specific primers for GAD25, i.e., a forward primer in exon 6 and a reverse primer in the last part of exon 7 (Fig. 1). The results show an expression of this GAD25 form in all fetal and adult pancreas specimens (Fig. 2C). In general, there appeared to be no differences in expression levels by RT-PCR between the different gestational ages or the adult samples for all of the primer combinations used. Fig. 2A-C Results of RT-PCR experiments of seven representative samples, with primers against POLR2A (A), GAD67 (B), and GAD25 (C). The arrows indicate the sizes of the PCR products, which are 188 bp for POLR2A (A); 200, 280, and 286 bp for GAD67, respectively (B); and 189 bp for GAD25 (C)
###end p 23
###begin p 24
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-C</bold>
###xml 88 94 88 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">POLR2A</italic>
###xml 96 97 96 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 100 105 100 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 107 108 107 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 115 120 115 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD25</italic>
###xml 122 123 122 123 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 130 136 130 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 198 204 198 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">POLR2A</italic>
###xml 206 207 206 207 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 235 240 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 256 257 256 257 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 275 280 275 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD25</italic>
###xml 282 283 282 283 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
A-C Results of RT-PCR experiments of seven representative samples, with primers against POLR2A (A), GAD67 (B), and GAD25 (C). The arrows indicate the sizes of the PCR products, which are 188 bp for POLR2A (A); 200, 280, and 286 bp for GAD67, respectively (B); and 189 bp for GAD25 (C)
###end p 24
###begin title 25
Sequence Analysis
###end title 25
###begin p 26
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 339 340 339 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 524 529 524 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 669 674 660 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD25</italic>
###xml 776 782 767 773 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 3</label>
###xml 824 829 815 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 905 909 896 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane</italic>
###xml 924 929 915 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 961 967 952 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lane 2</italic>
###xml 1042 1048 1033 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 3</italic>
###xml 782 1092 773 1083 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="27">Four distinct RT-PCR products appear when <italic>GAD67</italic> primers are used in this human fetal pancreas of 16 weeks of gestation. In <italic>lane</italic> 1, the native <italic>GAD67</italic> PCR product of 200 bp is seen. <italic>Lane 2</italic> represents the PCR products of the I-80 and I-86 splice variants, whereas <italic>lane 3</italic> shows the newly found PCR product of 330 bp</p>
###xml 782 1092 773 1083 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="27">Four distinct RT-PCR products appear when <italic>GAD67</italic> primers are used in this human fetal pancreas of 16 weeks of gestation. In <italic>lane</italic> 1, the native <italic>GAD67</italic> PCR product of 200 bp is seen. <italic>Lane 2</italic> represents the PCR products of the I-80 and I-86 splice variants, whereas <italic>lane 3</italic> shows the newly found PCR product of 330 bp</p></caption>
###xml 1092 1092 1083 1083 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="12022_2007_Article_3_Fig3" id="MO3"/>
###xml 776 1092 767 1083 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig. 3</label><caption><p textid="27">Four distinct RT-PCR products appear when <italic>GAD67</italic> primers are used in this human fetal pancreas of 16 weeks of gestation. In <italic>lane</italic> 1, the native <italic>GAD67</italic> PCR product of 200 bp is seen. <italic>Lane 2</italic> represents the PCR products of the I-80 and I-86 splice variants, whereas <italic>lane 3</italic> shows the newly found PCR product of 330 bp</p></caption><graphic position="anchor" xlink:href="12022_2007_Article_3_Fig3" id="MO3"/></fig>
###xml 1092 1098 1083 1089 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 4</label>
###xml 1098 1154 1089 1145 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="28">Forward sequence of the additional PCR product of 330 bp</p>
###xml 1098 1154 1089 1145 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="28">Forward sequence of the additional PCR product of 330 bp</p></caption>
###xml 1154 1154 1145 1145 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="12022_2007_Article_3_Fig4" id="MO4"/>
###xml 1092 1154 1083 1145 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig. 4</label><caption><p textid="28">Forward sequence of the additional PCR product of 330 bp</p></caption><graphic position="anchor" xlink:href="12022_2007_Article_3_Fig4" id="MO4"/></fig>
###xml 518 523 <span type="species:ncbi:9606">human</span>
###xml 855 860 <span type="species:ncbi:9606">human</span>
Sequence analysis with specific forward and reverse primers revealed that the two additional PCR products of 280 and 286 bp consisted of the adult form with an insertion of either the first 80 or 86 bp of exon 7. The additional product of 330 bp (Fig. 3), consisting of exons 6 to 9, with an insertion of 68 bp between exons 6 and 7 (Fig. 4), appeared to be a new splice product. This new exon was flanked by authentic splice junctions: 5'-AG/GT-3'. The additional sequence was homologous to a part of intron 6 of the human GAD67 gene (51.128-51.195 of Gen-Banktrade mark accession number AC007405). The first 213 amino acids of the predicted protein are homologous to GAD25, followed by another 26 amino acids. The predicted molecular weight would approximately be 29.3 kDa. Fig. 3Four distinct RT-PCR products appear when GAD67 primers are used in this human fetal pancreas of 16 weeks of gestation. In lane 1, the native GAD67 PCR product of 200 bp is seen. Lane 2 represents the PCR products of the I-80 and I-86 splice variants, whereas lane 3 shows the newly found PCR product of 330 bpFig. 4Forward sequence of the additional PCR product of 330 bp
###end p 26
###begin p 27
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 123 127 123 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane</italic>
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 179 185 179 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lane 2</italic>
###xml 260 266 260 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 3</italic>
###xml 73 78 <span type="species:ncbi:9606">human</span>
Four distinct RT-PCR products appear when GAD67 primers are used in this human fetal pancreas of 16 weeks of gestation. In lane 1, the native GAD67 PCR product of 200 bp is seen. Lane 2 represents the PCR products of the I-80 and I-86 splice variants, whereas lane 3 shows the newly found PCR product of 330 bp
###end p 27
###begin p 28
Forward sequence of the additional PCR product of 330 bp
###end p 28
###begin title 29
Discussion
###end title 29
###begin p 30
###xml 23 26 23 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD</italic>
###xml 139 142 139 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD</italic>
###xml 165 170 165 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD25</italic>
###xml 308 313 308 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 318 323 318 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD25</italic>
###xml 440 445 440 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 199 204 <span type="species:ncbi:9606">human</span>
###xml 245 250 <span type="species:ncbi:9606">human</span>
###xml 561 566 <span type="species:ncbi:9606">human</span>
The potential role for GAD in pancreas development and the lack of knowledge about the distribution of the isoforms and splice variants of GAD led us to investigate GAD67 and GAD25 expression in the human fetal pancreas. We performed RT-PCR, on human fetal and adult pancreases, and found mRNA expression of GAD67 and GAD25 from 14 weeks gestation onward until term, as well as in the adult pancreas specimens. Apart from the adult form of GAD67, the RT-PCR experiments revealed three additional splice variants, which have not been described previously in the human pancreas.
###end p 30
###begin p 31
###xml 260 265 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 523 524 523 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 525 526 525 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 158 163 <span type="species:ncbi:10090">mouse</span>
###xml 289 294 <span type="species:ncbi:9606">human</span>
###xml 359 364 <span type="species:ncbi:9606">human</span>
###xml 473 481 <span type="species:ncbi:9606">patients</span>
Our study revealed GAD67 mRNA expression in all fetal and adult pancreases. Whereas GAD67 expression at the mRNA and protein level is well established in the mouse pancreas, only a few studies, using RNA protection assay analysis and RT-PCR, have demonstrated GAD67 mRNA expression in the human pancreas [11, 17]. In contrast, GAD67 was never detected in the human pancreas at the protein level, although some studies found GAD67 autoantibodies in type 1 diabetes mellitus patients, in the absence of GAD65 autoantibodies [5-7]. An explanation for the negative findings of previous studies could be that the GAD67 protein has already degraded because the halflife of the GAD67 protein is less than 4 h [18].
###end p 31
###begin p 32
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 331 336 331 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 426 431 426 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 465 470 465 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD25</italic>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 714 715 714 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 717 718 717 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 763 768 763 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 851 852 851 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 176 181 <span type="species:ncbi:9606">human</span>
###xml 513 518 <span type="species:ncbi:9606">human</span>
###xml 701 706 <span type="species:ncbi:10090">mouse</span>
###xml 740 745 <span type="species:ncbi:10090">mouse</span>
###xml 1090 1095 <span type="species:ncbi:9606">human</span>
According to the literature, alternative splicing of the GAD67 gene results in at least four mRNA products [3, 4]. In our study, we demonstrate four GAD67 mRNA isoforms in the human fetal and adult pancreas samples. The first discovered transcript was an mRNA product, which lacks exon 7 and encodes for the native 67-kDa protein (GAD67) (see the "Results" section). A second transcript comprised the first seven exons of the GAD67 gene, encoding a 25-kDa protein (GAD25). This variant was previously reported in human nonneural tissues by Chessler et al. [19]. A third and fourth transcript contained the first 80 or 86 bp of exon 7. So far, these mRNA variants have only been described in embryonic mouse brain [3, 4]. In contrast to the mouse brain, where the GAD67 mRNA splice variants seem to have a developmentally regulated expression pattern [4], we did not see an increase of the 80-bp splice form, nor did we detect a decrease of the 86-bp during gestation, compared to each other in the same sample. In addition, all different mRNA isoforms described above were detected in most human fetal pancreases from 14 weeks of gestation until term even in the adult pancreases. It should be noted, though, that these experiments were not set up to yield quantitative data and therefore must be interpreted with caution.
###end p 32
###begin p 33
###xml 94 99 94 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 278 283 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD25</italic>
###xml 394 395 394 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 705 706 705 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 463 468 <span type="species:ncbi:10090">mouse</span>
The additional RT-PCR product of 330 bp represents a heretofore undescribed splice variant of GAD67, with an insertion of an unknown exon before the I-86 insert. The predicted protein would consist of 213 amino acids, of which the first part consists of the same amino acids as GAD25, followed by another 26 amino acids, and would have a molecular weight of approximately 29 kDa. Szabo et al. [4] observed two isoforms of approximately 31 and 32 kDa in embryonic mouse brain by Western blot. These products were assumed to be the result of posttranslational modifications. The predicted protein of our newly found splice variant might actually represent one or both of the proteins found by Szabo et al. [4].
###end p 33
###begin p 34
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 107 112 107 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 217 222 217 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 326 331 326 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAD67</italic>
###xml 392 397 <span type="species:ncbi:9606">human</span>
###xml 443 448 <span type="species:ncbi:9606">human</span>
In summary, we found GAD67 mRNA expression during the entire gestational period investigated. In addition, GAD67 splice variants were present in both fetal and adult pancreases. We also found a heretofore undescribed GAD67 mRNA splice variant, which is also found in the fetal and adult pancreases. These results suggest that GAD67 and its splice variants might play a role in the developing human fetal pancreas and in the maintenance of the human adult pancreas.
###end p 34
###begin p 35
###xml 114 119 <span type="species:ncbi:9606">human</span>
We are grateful to the Erasmus MC Tissue Bank (Department of Pathology, Rotterdam, The Netherlands) for providing human fetal and adult frozen pancreas tissue. We gratefully acknowledge Frank van der Panne (Department of Pathology, Josephine Nefkens Institute, Erasmus MC, Rotterdam, The Netherlands) for his assistance with the generation of the figures. This study was supported by a grant from the European UnionQLRT-1999-00276 (MONODIAB). The authors declare that there is no conflict of interest that would prejudice the impartiality of this scientific work.
###end p 35
###begin title 36
References
###end title 36
###begin article-title 37
###xml 4 9 <span type="species:ncbi:9606">human</span>
Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene
###end article-title 37
###begin article-title 38
Structural features and regulatory properties of the brain glutamate decarboxylases
###end article-title 38
###begin article-title 39
###xml 105 110 <span type="species:ncbi:9606">human</span>
Alternative splicing of GAD67 results in the synthesis of a third form of glutamic-acid decarboxylase in human islets and other non-neural tissues
###end article-title 39
###begin article-title 40
Distinct protein forms are produced from alternatively spliced bicistronic glutamic acid decarboxylase mRNAs during development
###end article-title 40
###begin article-title 41
Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM
###end article-title 41
###begin article-title 42
A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM
###end article-title 42
###begin article-title 43
Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus
###end article-title 43
###begin article-title 44
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 53 56 <span type="species:ncbi:10116">rat</span>
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets
###end article-title 44
###begin article-title 45
###xml 36 41 <span type="species:ncbi:9606">human</span>
Ontogeny and tissue distribution of human GAD expression
###end article-title 45
###begin article-title 46
###xml 58 61 <span type="species:ncbi:10116">rat</span>
###xml 66 71 <span type="species:ncbi:9606">human</span>
Differential expression of glutamic acid decarboxylase in rat and human islets
###end article-title 46
###begin article-title 47
###xml 72 77 <span type="species:ncbi:9606">human</span>
Glutamic acid decarboxylase-67 (GAD67): expression relative to GAD65 in human islets and mapping of autoantibody epitopes
###end article-title 47
###begin article-title 48
###xml 26 29 <span type="species:ncbi:10116">rat</span>
Differential detection of rat islet and brain glutamic acid decarboxylase (GAD) isoforms with sequence-specific peptide antibodies
###end article-title 48
###begin article-title 49
###xml 138 143 <span type="species:ncbi:10090">mouse</span>
###xml 148 151 <span type="species:ncbi:10116">rat</span>
Localization and quantitation of expression of two glutamate decarboxylase genes in pancreatic beta-cells and other peripheral tissues of mouse and rat
###end article-title 49
###begin article-title 50
Developmentally regulated expression of an exon containing a stop codon in the gene for glutamic acid decarboxylase
###end article-title 50
###begin article-title 51
###xml 75 78 <span type="species:ncbi:10116">rat</span>
Differential regulation of adult and embryonic glutamate decarboxylases in rat dentate granule cells after kainate-induced limbic seizures
###end article-title 51
###begin article-title 52
Two isoforms of glutamate decarboxylase: why?
###end article-title 52
###begin article-title 53
###xml 76 81 <span type="species:ncbi:9606">human</span>
Cloning and expression of large isoform of glutamic acid decarboxylase from human pancreatic islet
###end article-title 53
###begin article-title 54
Differential islet cell expression of two glutamate decarboxylases, both autoantigens in diabetes
###end article-title 54
###begin article-title 55
Immune reactivity to GAD25 in type 1 diabetes mellitus
###end article-title 55

